Integrated analysis of network pharmacology and microbiome reveals the therapeutic effect of ligustrazine dry powder inhaler in COPD inflammation
Published: 17 June 2024| Version 1 | DOI: 10.17632/5xh93tcgwz.1
Contributor:
Xuejing LuanDescription
There is the raw data for the article submitted to the journal “JOURNAL OF ETHNOPHARMACOLOGY””. The name of this paper is “Integrated analysis of network pharmacology and microbiome reveals the therapeutic effect of ligustrazine dry powder inhaler in COPD inflammation”.
Files
Categories
Chronic Obstructive Pulmonary Disease, Pulmonary Disorder, Microbiota